International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 7, Issue 2 (March-April 2025) Submit your research before last 3 days of April to publish your research paper in the issue of March-April.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 7 Issue 2
March-April 2025

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Monoclonal Antibodies in Cancer Therapy: Mechanisms, Clinical Applications, and Future Perspectives

Author(s) ANJALI SONI, NEHA BHALAVI, ARUN KUMAR GUPTA
Country India
Abstract Monoclonal antibodies (mAbs) have revolutionized cancer therapy by offering targeted treatment options with improved specificity and efficacy compared to conventional chemotherapy and radiation therapy. These biologic agents work through diverse mechanisms, including direct tumor cell targeting, immune system modulation, and inhibition of tumor angiogenesis. Over the past two decades, significant advancements in monoclonal antibody engineering, such as antibody-drug conjugates (ADCs), bispecific antibodies, and immune checkpoint inhibitors, have enhanced their clinical utility. Despite their success, challenges such as resistance mechanisms, high costs, and limited accessibility remain. This thesis explores the structure, mechanisms of action, clinical applications, and combination strategies involving monoclonal antibodies. Additionally, emerging trends, including CAR-T cell therapy integration and natural product-enhanced mAbs, are discussed to highlight future directions in cancer immunotherapy. By providing a comprehensive analysis of their role in oncology, this study aims to contribute to the ongoing development of more effective and personalized cancer treatments.
Keywords Monoclonal antibodies, Cancer therapy, Immune checkpoint inhibitors, Antibody-drug conjugates, Bispecific antibodies, CAR-T cell therapy, Targeted therapy, Tumor microenvironment, Immunotherapy, Precision medicine.
Published In Volume 7, Issue 2, March-April 2025
Published On 2025-03-08
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 7 Isu 2Cover Page Vol 7 Isu 1Cover Page Vol 6 Isu 6

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com